CRD.B vs. EHTH, MMC, AON, AJG, BRO, WDH, SLQT, RDZN, GOCO, and FANH
Should you be buying Crawford & Company stock or one of its competitors? The main competitors of Crawford & Company include eHealth (EHTH), Marsh & McLennan Companies (MMC), AON (AON), Arthur J. Gallagher & Co. (AJG), Brown & Brown (BRO), Waterdrop (WDH), SelectQuote (SLQT), Roadzen (RDZN), GoHealth (GOCO), and Fanhua (FANH). These companies are all part of the "insurance agents, brokers, & service" industry.
Crawford & Company (NYSE:CRD.B) and eHealth (NASDAQ:EHTH) are both small-cap business services companies, but which is the better stock? We will contrast the two companies based on the strength of their valuation, risk, earnings, institutional ownership, media sentiment, profitability, community ranking, dividends and analyst recommendations.
In the previous week, eHealth had 2 more articles in the media than Crawford & Company. MarketBeat recorded 3 mentions for eHealth and 1 mentions for Crawford & Company. eHealth's average media sentiment score of 1.19 beat Crawford & Company's score of 0.00 indicating that eHealth is being referred to more favorably in the news media.
11.0% of Crawford & Company shares are held by institutional investors. Comparatively, 79.5% of eHealth shares are held by institutional investors. 51.0% of Crawford & Company shares are held by company insiders. Comparatively, 4.1% of eHealth shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.
eHealth has a consensus price target of $10.00, indicating a potential upside of 68.92%. Given eHealth's higher probable upside, analysts plainly believe eHealth is more favorable than Crawford & Company.
Crawford & Company has a net margin of 1.76% compared to eHealth's net margin of -5.36%. Crawford & Company's return on equity of 26.52% beat eHealth's return on equity.
eHealth received 314 more outperform votes than Crawford & Company when rated by MarketBeat users. Likewise, 62.19% of users gave eHealth an outperform vote while only 54.02% of users gave Crawford & Company an outperform vote.
Crawford & Company has a beta of 0.85, meaning that its stock price is 15% less volatile than the S&P 500. Comparatively, eHealth has a beta of 0.49, meaning that its stock price is 51% less volatile than the S&P 500.
Crawford & Company has higher revenue and earnings than eHealth. eHealth is trading at a lower price-to-earnings ratio than Crawford & Company, indicating that it is currently the more affordable of the two stocks.
Summary
Crawford & Company beats eHealth on 9 of the 16 factors compared between the two stocks.
This chart shows the number of new MarketBeat users adding CRD.B and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
CRD.B vs. The Competition
Crawford & Company Competitors List
Related Companies and Tools
